US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 45.500
  • +1.360+3.08%
Close Oct 18 16:00 ET
  • 45.500
  • 0.0000.00%
Post 16:02 ET
2.59BMarket Cap-7000P/E (TTM)

Agios Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
28.35%8.62M
46.00%8.19M
88.36%26.82M
64.80%7.1M
110.44%7.4M
20.24%6.71M
574.16%5.61M
14.24M
4.31M
3.52M
Operating revenue
28.35%8.62M
46.00%8.19M
88.36%26.82M
64.80%7.1M
110.44%7.4M
20.24%6.71M
574.16%5.61M
--14.24M
--4.31M
--3.52M
Cost of revenue
34.93%1.5M
13.18%627K
69.07%2.88M
41.89%586K
22.44%633K
154.71%1.11M
63.42%554K
1.7M
413K
517K
Gross profit
27.05%7.12M
49.59%7.56M
90.99%23.94M
67.23%6.52M
125.61%6.77M
8.88%5.6M
925.35%5.06M
12.54M
3.9M
3M
Operating expense
13.73%112.94M
4.15%99.63M
3.45%415.43M
9.44%112.79M
14.43%107.66M
-3.39%99.3M
-5.87%95.67M
6.12%401.58M
-1.68%103.07M
3.22%94.09M
Selling and administrative expenses
16.86%35.54M
9.33%31.01M
-1.45%119.9M
7.73%35.31M
-11.33%25.82M
7.59%30.41M
-9.99%28.37M
0.19%121.67M
3.94%32.77M
7.26%29.12M
Research and development costs
12.35%77.4M
1.96%68.62M
5.58%295.53M
10.23%77.49M
25.98%81.84M
-7.55%68.9M
-4.02%67.3M
8.93%279.91M
-4.09%70.3M
1.51%64.97M
Operating profit
-12.93%-105.82M
-1.61%-92.07M
-0.63%-391.49M
-7.16%-106.28M
-10.77%-100.9M
4.04%-93.7M
10.41%-90.61M
-2.81%-389.05M
5.39%-99.17M
0.07%-91.09M
Net non-operating interest income expense
-1.62%8.12M
9.86%8.89M
160.64%33.34M
32.92%8.62M
119.36%8.38M
360.35%8.25M
1,065.85%8.09M
1,430.26%12.79M
1,854.22%6.49M
1,391.41%3.82M
Non-operating interest income
-1.62%8.12M
9.86%8.89M
160.64%33.34M
32.92%8.62M
119.36%8.38M
360.35%8.25M
1,065.85%8.09M
1,430.26%12.79M
1,854.22%6.49M
1,391.41%3.82M
Other net income (expense)
-3.72%1.58M
8.64%1.63M
-95.81%6.06M
-98.67%1.71M
-78.32%1.2M
-59.42%1.64M
-73.51%1.5M
585.52%144.45M
2,085.92%129.21M
-16.75%5.53M
Special income (charges)
----
----
--0
--0
--0
----
----
1,974.17%137.7M
4,737.42%127.85M
122.60%4.44M
-Gain on sale of business
----
----
--0
--0
--0
----
----
1,974.17%137.7M
4,737.42%127.85M
122.60%4.44M
Other non- operating income (expenses)
-3.72%1.58M
8.64%1.63M
-10.28%6.06M
26.23%1.71M
10.72%1.2M
22.66%1.64M
-49.41%1.5M
-53.24%6.75M
-58.48%1.36M
-76.69%1.08M
Income before tax
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
34.98%-231.8M
137.05%36.53M
2.98%-81.75M
Income tax
Net income
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
-114.44%-231.8M
138.60%36.53M
7.91%-81.75M
Net income continuous Operations
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
34.98%-231.8M
137.05%36.53M
2.98%-81.75M
Net income discontinuous operations
----
----
--0
----
----
----
----
--0
----
----
Minority interest income
Net income attributable to the parent company
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
-114.44%-231.8M
138.60%36.53M
7.91%-81.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
-114.44%-231.8M
138.60%36.53M
7.91%-81.75M
Basic earnings per share
-11.92%-1.69
1.36%-1.45
-49.65%-6.33
-356.72%-1.72
-10.07%-1.64
10.12%-1.51
15.52%-1.47
-115.93%-4.23
138.51%0.67
4.49%-1.49
Diluted earnings per share
-11.92%-1.69
1.36%-1.45
-49.65%-6.33
-356.72%-1.72
-10.07%-1.64
10.12%-1.51
15.52%-1.47
-115.93%-4.23
138.51%0.67
4.49%-1.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 28.35%8.62M46.00%8.19M88.36%26.82M64.80%7.1M110.44%7.4M20.24%6.71M574.16%5.61M14.24M4.31M3.52M
Operating revenue 28.35%8.62M46.00%8.19M88.36%26.82M64.80%7.1M110.44%7.4M20.24%6.71M574.16%5.61M--14.24M--4.31M--3.52M
Cost of revenue 34.93%1.5M13.18%627K69.07%2.88M41.89%586K22.44%633K154.71%1.11M63.42%554K1.7M413K517K
Gross profit 27.05%7.12M49.59%7.56M90.99%23.94M67.23%6.52M125.61%6.77M8.88%5.6M925.35%5.06M12.54M3.9M3M
Operating expense 13.73%112.94M4.15%99.63M3.45%415.43M9.44%112.79M14.43%107.66M-3.39%99.3M-5.87%95.67M6.12%401.58M-1.68%103.07M3.22%94.09M
Selling and administrative expenses 16.86%35.54M9.33%31.01M-1.45%119.9M7.73%35.31M-11.33%25.82M7.59%30.41M-9.99%28.37M0.19%121.67M3.94%32.77M7.26%29.12M
Research and development costs 12.35%77.4M1.96%68.62M5.58%295.53M10.23%77.49M25.98%81.84M-7.55%68.9M-4.02%67.3M8.93%279.91M-4.09%70.3M1.51%64.97M
Operating profit -12.93%-105.82M-1.61%-92.07M-0.63%-391.49M-7.16%-106.28M-10.77%-100.9M4.04%-93.7M10.41%-90.61M-2.81%-389.05M5.39%-99.17M0.07%-91.09M
Net non-operating interest income expense -1.62%8.12M9.86%8.89M160.64%33.34M32.92%8.62M119.36%8.38M360.35%8.25M1,065.85%8.09M1,430.26%12.79M1,854.22%6.49M1,391.41%3.82M
Non-operating interest income -1.62%8.12M9.86%8.89M160.64%33.34M32.92%8.62M119.36%8.38M360.35%8.25M1,065.85%8.09M1,430.26%12.79M1,854.22%6.49M1,391.41%3.82M
Other net income (expense) -3.72%1.58M8.64%1.63M-95.81%6.06M-98.67%1.71M-78.32%1.2M-59.42%1.64M-73.51%1.5M585.52%144.45M2,085.92%129.21M-16.75%5.53M
Special income (charges) ----------0--0--0--------1,974.17%137.7M4,737.42%127.85M122.60%4.44M
-Gain on sale of business ----------0--0--0--------1,974.17%137.7M4,737.42%127.85M122.60%4.44M
Other non- operating income (expenses) -3.72%1.58M8.64%1.63M-10.28%6.06M26.23%1.71M10.72%1.2M22.66%1.64M-49.41%1.5M-53.24%6.75M-58.48%1.36M-76.69%1.08M
Income before tax -14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M34.98%-231.8M137.05%36.53M2.98%-81.75M
Income tax
Net income -14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M-114.44%-231.8M138.60%36.53M7.91%-81.75M
Net income continuous Operations -14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M34.98%-231.8M137.05%36.53M2.98%-81.75M
Net income discontinuous operations ----------0------------------0--------
Minority interest income
Net income attributable to the parent company -14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M-114.44%-231.8M138.60%36.53M7.91%-81.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M-114.44%-231.8M138.60%36.53M7.91%-81.75M
Basic earnings per share -11.92%-1.691.36%-1.45-49.65%-6.33-356.72%-1.72-10.07%-1.6410.12%-1.5115.52%-1.47-115.93%-4.23138.51%0.674.49%-1.49
Diluted earnings per share -11.92%-1.691.36%-1.45-49.65%-6.33-356.72%-1.72-10.07%-1.6410.12%-1.5115.52%-1.47-115.93%-4.23138.51%0.674.49%-1.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data